Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney disease

Conclusions:
We found that ARB use during the pre-dialysis period is associated with a lower prevalence of CHF in the non-dialysis Japanese patients with Stage 5 CKD, suggesting a possible prevention of dialysis-requiring CHF by ARBs, in non-dialysis Japanese patients with Stage 5 CKD.

Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - December 23, 2015 Category: Biomedical Science Authors: Ikeda, M., Nakao, M., Hirano, K., Yokoyama, K., Yokoo, T., Joki, N., Ando, R., Shinoda, T., Inaguma, D., Yamaka, T., Komatsu, Y., Koiwa, F., Sakaguchi, T., Negi, S., Shigematsu, T. Tags: Original Articles Source Type: research